Robert Molander

Robert Molander

Director/Board Member at XSPRAY PHARMA AB

Net worth: 15 725 $ as of 29/06/2026

61 year
Health Technology
Consumer Services
Technology Services

Profile

Robert Molander is currently Chief Executive Officer at Stratfox Healthcare Group LLC since 2016.
Mr. Molander is Director at Scibase Intressenter AB, Director at SciBase AB, Independent Director at SciBase Holding AB, and Director at Biosergen AB since 2024.
Former roles include Chief Commercial Officer at Trialbee AB from 2018 to 2021 and Chief Commercial Officer at Infant Bacterial Therapeutics AB from 2022 to 2024.
Education includes an MBA from the University of Washington and an undergraduate degree from Miami University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
30/12/2025 10,283 ( 0.02% ) 15 725 $ 29/06/2026

Robert Molander active positions

CompaniesPositionStart
XSPRAY PHARMA AB Director/Board Member 18/05/2022
BIOSERGEN AB Director/Board Member 13/06/2024
SCIBASE HOLDING AB (PUBL) Director/Board Member -
Stratfox Healthcare Group LLC
Chief Executive Officer 31/12/2015
Scibase Intressenter AB
Director/Board Member -
Scibase AB
Director/Board Member -

Former positions of Robert Molander

CompaniesPositionEnd
INFANT BACTERIAL THERAPEUTICS AB Director/Board Member 31/12/2021
Corporate Officer/Principal 01/01/2021
See the detail of Robert Molander's experience

Training of Robert Molander

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

12

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Consumer Services

Consumer Services

Health Technology

Health Technology

Scibase Intressenter AB

Technology Services

Health Technology

Scibase AB

Health Technology

Stratfox Healthcare Group LLC

  1. Stock Market
  2. Insiders
  3. Robert Molander